The effect of Levetiracetam on the treatment of positive and negative symptoms of schizophrenia

Phase 3

• Conditions: Schizophrenia.; Schizophrenia

• Registration Number: IRCT20221108056437N1
• Lead Sponsor: niversity of social welfare and rehabilitation sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Schizophrenia diagnosis by a psychiatrist
The occurrence of positive and negative symptoms in the symptoms of the disorder based on the Scale of positive and negative symptoms of schizophrenia
The absence of other mental disorders at the same time, based on the psychiatrist's diagnosis, medical records and interview with the patient
The absence of mental retardation or chronic diseases such as epilepsy, according to the psychiatrist's diagnosis
.Not having in the type of drugs used

Exclusion Criteria

Schizophrenia diagnosis by a psychiatrist in patients admitted to Razi Hospital in a certain period of time
Not suffering from other mental illnesses such as mental retardation
Not suffering from a chronic physical disease such as epilepsy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The score of positive and negative symptoms of schizophrenia in positive and negative syndrom scale questionnaire. Timepoint: Investigating the positive and negative symptoms of schizophrenia at the beginning of the study and 6 weeks after starting levetiracetam. Method of measurement: Positive and negative syndrom scale.